Efforts to reform the Part B DMEPOS benefit, a robust pipeline of biologics, and implementation of the Inflation Reduction Act will make 2024 a year full of change for infusion providers. Hear from Connie Sullivan, President and CEO of the National Home Infusion Association, how NHIA views opportunities and challenges facing the industry in 2024, and what NHIA is doing to position the industry for success.